Literature DB >> 24246312

In vitro microdialysis recovery and delivery investigation of cytokines as prerequisite for potential biomarker profiling.

Claudia Kirbs1, Charlotte Kloft2.   

Abstract

Cytokines as immunomodulatory proteins are secreted by immune and tissue cells mediating immune responses, e.g. inflammation. The use of microdialysis as a minimally invasive technique for sampling interstitial fluid might provide the basis for biomarker profiling for diseases and therapy monitoring. The objectives of this investigation were to develop reproducible methods and apply them to define applicability limits to quantify cytokines in microdialysate. In vitro microdialysis recovery and delivery investigations were performed utilising a standardised system exploring analyte adsorption, pH effects, the infuence of cytokine concentration and temperature of the catheter surrounding medium. A Ringer's/human albumin solution was used as microperfusate and catheter surrounding medium; interleukin 6, 8 and 10 (IL-6, IL-8, IL-10) and tumour necrosis factor alpha (TNF-α) served as model cytokines. Microdialysate was sampled (n=3) at flow rates of 0.3-5.0μL/min using 3 linear probes. All samples were measured using a validated flow-cytometry method adapted to microdialysate. Relative recoveries of the individual cytokines decreased exponentially with increasing flow rates and were not influenced by the catheter surrounding medium concentration but recovery of IL-6, IL-10 and TNF-α by the pH value. Relative recovery and relative delivery of IL-8 were of comparable extent and increased with higher temperatures. For the other cytokines, however, negative values occurred for relative delivery probably due to ultrafiltration. Clinical application of microdialysis of cytokines is principally feasible if the many influencing factors are controlled. Since relative delivery determination is only reliable for IL-8, retrodialysis or similar calibration methods must be avoided. As future perspective, in vivo μD feasibility should next be demonstrated.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cytokine; Interleukin 10; Interleukin 6; Interleukin 8; Microdialysis; Tumour necrosis factor alpha

Mesh:

Substances:

Year:  2013        PMID: 24246312     DOI: 10.1016/j.ejps.2013.11.006

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  4 in total

1.  Microdialysis of Drug and Drug Metabolite: a Comprehensive In Vitro Analysis for Voriconazole and Voriconazole N-oxide.

Authors:  Josefine Schulz; Robin Michelet; Markus Zeitlinger; Gerd Mikus; Charlotte Kloft
Journal:  Pharm Res       Date:  2022-09-28       Impact factor: 4.580

2.  Cytokine and Chemokine Recovery Is Increased by Colloid Perfusates during Dermal Microdialysis.

Authors:  Sven R Quist; Claudia Kirbs; Charlotte Kloft; Harald P Gollnick
Journal:  Materials (Basel)       Date:  2018-04-27       Impact factor: 3.623

3.  The Skin Reservoir Model: A Tool for Evaluating Microdialysis Sampling of Large Biomarkers from Human Skin.

Authors:  Katrine Baumann; Sidsel Falkencrone; Niels Peter Knudsen; Anders Woetmann; Sally Dabelsteen; Per Stahl Skov
Journal:  Acta Derm Venereol       Date:  2020-01-07       Impact factor: 3.875

4.  Microdialysis Sampling from Wound Fluids Enables Quantitative Assessment of Cytokines, Proteins, and Metabolites Reveals Bone Defect-Specific Molecular Profiles.

Authors:  Yvonne Förster; Johannes R Schmidt; Dirk K Wissenbach; Susanne E M Pfeiffer; Sven Baumann; Lorenz C Hofbauer; Martin von Bergen; Stefan Kalkhof; Stefan Rammelt
Journal:  PLoS One       Date:  2016-07-21       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.